Clinical Trial Update: Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography [NA]

View source ↗

Summary

The clinical trial NCT03002480 investigating individualized bypassing agent therapy for hemophilia A with inhibitors using thromboelastography has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Hemophilia a with Inhibitors | NA | Status: WITHDRAWN